Fosdesdenosine sipalabenamide

N/A

Report date: 2025/03/12 16:56:34

Base Information

Drug NameFosdesdenosine sipalabenamide
Drug Alias NameProTide transformation of 3'-deoxyadenosineNUC-7738
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionRNA synthesis inhibitors
TargetsRibonucleic Acid
Therapy Area/IndicationsSolid tumoursMelanomaLymphoma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCardiff University
China Registration ClassN/A

Develop Information

Active CompaniesNucana BiomedCardiff UniversityNucana Plc
Inactive CompaniesN/A
Active IndicationsSolid tumoursMelanomaLymphoma +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A